1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6096068B91868566585256E630057C251
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/the-rd-quality-function-staffing-and-structure-metrics?opendocument
18
19opendocument
2018.97.14.85
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Quality, Compliance and Regulatory » Structure,Staffing and Execution

The R&D Quality Function: Staffing and Structure Metrics

DB Image

ID: 4591


Features:

Metrics, Graphics, Summary Matrix


Pages/Slides: 21


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Study Overview

R&D quality functions within pharmaceutical companies do not always have access to information about how they stack up against peer functions in other companies. This twenty-one page report summarizes a Best Practices, LLC survey on the staffing and structure of R&D quality functions. It is designed to help pharmaceutical companies measure themselves against industry leaders in the areas of staffing and structure.

Key Metrics
Fourteen companies provide benchmarking information on statistics contained in 23 charts, including but limited to the following:

1) The number of front line workers and supervisors/leaders for R&D quality assurance
2) The number of front line workers and supervisors/leaders for R&D quality control
3) The number of FTEs in discovery/basic research, toxicology/ADME, medical/clinical research, process and product development, manufacturing clinical research supply, regulatory affairs, computer systems and vendor management.
4) Changes in quality staffing as products move from development to production.

Methodology
This research originates from a Best Practices, LLC consulting project for a pharmaceutical client. Results are drawn from an online survey.


Industries Profiled:
Pharmaceutical; Health Care; Diagnostic; Medical Device; Biotech


Companies Profiled:
Sanofi-aventis; Medarex; Mayne; Cardinal Health; GlaxoSmithKline; Boehringer-Ingelheim; Abbott; Johnson & Johnson; Amgen; Lilly; Bristol-Myers Squibb

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.